期刊文献+

外源性HMGB1/mtDNA促进放疗残存胰腺癌细胞侵袭与迁移的作用及其机制 被引量:2

Radiotherapy-induced exogenous HMGB1/mtDNA promotes residual pancreatic cancer cells invasion and migration
原文传递
导出
摘要 目的探讨放疗诱导胰腺癌细胞释放的高迁移率族蛋白B1/线粒体DNA(HMGB1/mtDNA)对残存胰腺癌细胞侵袭与迁移的作用及其机制。方法不同剂量(0、8 Gy)X射线处理胰腺癌PaTu8988细胞后,酶联免疫吸附测定(ELISA)试剂盒检测放疗后上清HMGB1浓度、实时荧光定量PCR(qRT-PCR)检测放疗后上清mtDNA相对拷贝数。将放疗处理的胰腺癌细胞、外源性重组人高迁移率族蛋白B1(rhHMGB1)/mtDNA分别与PaTu8988细胞共培养,Transwell检测侵袭与迁移细胞数。外源性rhHMGB1/mtDNA培养PaTu8988细胞,蛋白质印迹法检测环鸟苷酸-腺苷酸合成酶(cGAS)、干扰素基因刺激蛋白(STING)、TANK结合激酶1(TBK1)和干扰素调节因子3(IRF3)蛋白水平变化;qRT-PCR检测干扰素-β(IFN-β)转录水平变化。同时构建HMGB1低表达(sh-HMGB1)、mtDNA部分缺失(ρ0)胰腺癌PaTu8988细胞株,放疗后与PaTu8988细胞共培养,蛋白质印迹法检测TBK1蛋白磷酸化水平变化。结果放疗诱导HMGB1(t=-18.429,P<0.001)和mtDNA相关基因COX1(t=-12.370,P=0.006)、COX2(t=-8.503,P=0.014)和COX3(t=-10.321,P=0.009)释放至胰腺癌细胞外。放疗的胰腺癌细胞与rhHMGB1/mtDNA均能够促进PaTu8988细胞的侵袭与迁移(t=-4.016,P=0.015;t=-0.563,P=0.006;t=-25.489,P=0.001;t=-19.157,P=0.003)。外源性rhHMGB1/mtDNA抑制PaTu8988细胞中cGAS(t=2.895,P=0.048)、STING(t=-13.354,P=0.005)、p-TBK1(Ser172)/TBK1(t=-7.347,P=0.012)和p-IRF3(Ser396)/IRF3(t=-3.698,P=0.021)蛋白的表达;同时降低了PaTu8988细胞中IFN-β的转录水平,t=3.186,P=0.033。结论放疗促进胰腺癌细胞释放HMGB1和mtDNA至胞外;放疗诱导的HMGB1/mtDNA通过抑制cGAS-STING通路的激活和IFN-β的生成促进残存胰腺癌细胞的侵袭与迁移。 Objective To investigate the effects of radiotherapy-induced HMGB1/mtDNA on the invasion and migration of residual pancreatic cancer cells and its mechanism.Methods After the treatment of pancreatic cancer PaTu8988cells with different doses of X-ray(0Gy and 8Gy),the concentration of HMGB1and the relative copy number of mtDNA in the supernatant after radiotherapy were detected by the enzyme linked immunosorbent assay(ELISA)kit and quantitative realtime fluorescence PCR(qRT-PCR)respectively.The pancreatic cancer cells treated with radiation or rhHMGB1/mtDNA were further co-cultured with PaTu8988cells respectively,and the cell numbers of invasion and migration were detected by Transwell.With the treatment of exogenous rhHMGB1/mtDNA in PaTu8988cells,the protein expression levels of cGAS,STING,TBK1and IRF3were detected by Western blotting and the interferon-beta(IFN-β)transcription level were also detected by qRT-PCR.Meanwhile,the pancreatic cancer cell line with the low expression of HMGB1(sh-HMGB1)or the partial deletion of mtDNA(ρ0)were constructed,which were co-cultured with PaTu8988cells after radiation.Western blotting were utilized to detect the protein phosphorylation level of TBK1.Results Radiotherapy promoted the release of HMGB1(t=-18.429,P<0.001)and mtDNA related genes like COX1(t=-12.370,P=0.006),COX2(t=-8.503,P=0.014)and COX3(t=-10.321,P=0.009)to the extracellular of PaTu8988cells.Both pancreatic cells treated with radiotherapy and rhHMGB1/mtDNA could promote the invasion and migration of PaTu8988cells(t=-4.016,P=0.015;t=-0.563,P=0.006;t=-25.489,P=0.001;t=-19.157,P=0.003).Exogenous rhHMGB1/mtDNA down-regulated the protein expression level of cGAS(t=2.895,P=0.048),STING(t=-13.354,P=0.005),p-TBK1(Ser172)/TBK1(t=-7.347,P=0.012)and p-IRF3(Ser 396)/IRF3(t=-3.698,P=0.021)and also reduced the transcription level of IFN-β(t=3.186,P=0.033).Conclusions Radiotherapy can promote the release of HMGB1and mtDNA to the extracellular of PaTu8988cells.Radiotherapy-induced HMGB1/mtDNA can cause the invasion and migration of residual pancreatic cancer cells by inhibiting the activation of the cGAS-STING pathway and the production of IFN-β.
作者 马秋莲 王鸣 石卉 郭亚欣 龚爱华 朱海涛 张礼荣 MA Qiu-lian;WANG Ming;SHI Hui;GUO Ya-xin;GONG Ai-hua;ZHU Hai-tao;ZHANG Li-rong(Department of Radiology,Affiliated Hospital of Jiangsu University,Zhenjiang 212001,China;School of Medicine,Jiangsu University,Zhengjiang 212013,China)
出处 《中华肿瘤防治杂志》 CAS 北大核心 2021年第17期1300-1307,共8页 Chinese Journal of Cancer Prevention and Treatment
基金 江苏省研究生科研与实践创新计划(SJCX19_0577) 镇江市科技创新资金(SH2020031) 新疆生产建设兵团社会发展科技攻关与成果转化计划(2016AD005)。
关键词 胰腺癌 侵袭 迁移 放射治疗 HMGB1/mtDNA cGAS-STING通路 pancreatic cancer invasion migration radiotherapy HMGB1/mtDNA cGAS-STING pathway
  • 相关文献

参考文献3

二级参考文献28

  • 1范贤明,张玲,张世波.STAT_1和PCNA在肺癌组织中的表达及其临床意义[J].泸州医学院学报,2005,28(1):7-10. 被引量:6
  • 2陈首英,刘福林,庞志刚,周玉娟.肺癌病人5年生存率及生存因素分析[J].预防医学文献信息,2004,10(1):1-3. 被引量:12
  • 3Yu H, Pardoll D, Jove R. STATs in cancer inflammation and immunity: a leading role for STAT3 [ J ]. Nat Rev Cancer, 2009, 9( 11 ) :798-809.
  • 4Catlett-Falcone R, Dalton WS, Jove R. STAT proteins as novel targets for cancer therapy. Signal transducer an acti- vator of transcription [ J ]. Curr Opinion Oncol, 1999, 11 (6) :490-496.
  • 5Schreiber RD, Old LJ, Smyth MJ. Cancer immunoedit- ing: integrating immunity' s roles in cancer suppression and promotion [ J]. Science, 2011, 311 (6024) : 1565- 1570.
  • 6Sakamoto E, Hato F, Kato T, et al. Type I and type II in- terferons delay human neutrophil apoptosis via activation of STAT3 and up-regulation of cellular inhibitor of apoptosis [J]. J Leukoc Biol, 2005, 78(1):301-309.
  • 7Meraz MA, White JM, Sheehan KC, et al. Targeted dis- ruption of the Statl gene in mice reveals unexpected phy- siologic specificity in tile JAK-STAT signaling pathway [J]. Cell, 1996, 84(3) :431-442.
  • 8Durbin JE, Fernandez-Sesma A, Lee CK, et al. Type I IFN modulates innate and specific antiviral immunity [ J ]. Immunol, 2000, 164(8) :4220-4228.
  • 9Kim HS, Lee MS. STAT1 as a key modulator of cell death [J]. Cell Signal, 2007, 19(3):454-465.
  • 10Klover PJ, Muller WJ, Robinson GW, et al. Loss of STAT1 from mouse mammary epithelium results in an in- creased Neu-induced tumor burden[ J]. Neoplasia, 2010, 12(11) : 899-905.

共引文献53

同被引文献5

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部